Pdt Partners, LLC Cabaletta Bio, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $36,812 - $160,395	-10,956 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $24,108 - $43,050	-3,444 Reduced 23.92%	10,956 $133,000
Q2 2021 Aug 16, 2021	BUY	$7.2 - $11.73 $103,680 - $168,912	14,400 New	14,400 $124,000
Q4 2020 Feb 16, 2021	SELL	$9.81 - $15.8 $139,135 - $224,091	-14,183 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.71 - $14.41 $13,962 - $20,721	1,438 Added 11.28%	14,183 $154,000
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $81,440 - $143,763	12,745 New	12,745 $142,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.